COVID-19 IgG Quantitative Antibody Blood Test of Abbott recieved CE mark Kumar Jeetendra | December 19, 2020 Abbott has received CE Mark for its new quantitative SARS-CoV-2 IgG (Immunoglobulin G) lab-based serology test. IgG antibody testing that gives a quantitative result (measuring the amount of antibodies) provides important insights to people as they recover from COVID-19 and help evaluate a person’s immune response to a vaccine. Countries around the world are preparing …
WHO team arrives in Wuhan to test sources of COVID-19 pandemic Kumar Jeetendra | January 14, 2021 A team of WHO experts arrived in the central Chinese city of Wuhan on Thursday to investigate the origins of the deadly coronavirus pandemic. Chinese Foreign Ministry spokesman Zhao Lijian on Tuesday reported that the team will fly from Singapore to Wuhan, where the virus first emerged in December 2019. The World Health Organisation team’s …
Covishield not to be taken by individuals seriously adversely affected by any of its fixings: Serum Institute Kumar Jeetendra | January 19, 2021 People who are severely allergic to any ingredient of COVID-19 vaccine”Covishield” are advised not to take it, Serum Institute of India said. According to the fact sheet for the vaccine recipient by the Serum Institute of India, an individual should not get the Covishield vaccine if the individual had a serious allergic reaction after a …
China says one billion COVID-19 vaccine dosages administered Kumar Jeetendra | June 21, 2021 China said on June 20 that it has administered over one billion doses of COVID-19 vaccines in the country. China has accelerated its pace of free COVID-19 vaccinations for the whole nation since late March and administered a billion doses by June 19, the National Health Commission (NHC) said. The NHC, however, did not say …
New class of drugs effective against SARS-COV-2 and many RNA viruses Kumar Jeetendra | July 4, 2024 Researchers may have discovered a new class of front-line drugs that can both prevent the spread of new viruses and limit their severity. In laboratory tests, the already available treatments showed promise in fighting a range of existing RNA viruses, including SARS-Cov-2 and other human coronaviruses. Scientists have identified a new class of drugs with …
